BIOMAT Database Logo BIOMAT Database Logo

Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride. 1985

J el-On, and L Weinrauch, and R Livshin, and Z Even-Paz, and G P Jacobs

UI MeSH Term Description Entries
D007895 Leishmania tropica A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects humans and rodents. This taxonomic complex includes species which cause a disease called Oriental sore which is a form of cutaneous leishmaniasis (LEISHMANIASIS, CUTANEOUS) of the Old World. Leishmania (Leishmania) tropica,Leishmania tropica minor,Leishmania leishmania tropica,Leishmania tropicas
D007896 Leishmaniasis A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). Leishmania Infection,Infection, Leishmania,Infections, Leishmania,Leishmania Infections,Leishmaniases
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D010303 Paromomycin An aminoglycoside antibacterial and antiprotozoal agent produced by species of STREPTOMYCES. Aminosidine,Catenulin,Estomycin,Hydroxymycin,Neomycin E,Gabbromycin,Humatin,Paramomycin,Paromomycin I,Paromomycin Phosphate,Paromomycin Sulfate,Paromomycin Sulfate (1:1),Paromomycin Sulfate (2:5),Paromomycin, beta-D-Glucopyranosyl-Isomer,Paromomycin, beta D Glucopyranosyl Isomer,beta-D-Glucopyranosyl-Isomer Paromomycin
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations

Related Publications

J el-On, and L Weinrauch, and R Livshin, and Z Even-Paz, and G P Jacobs
Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala.
November 2001, The American journal of tropical medicine and hygiene,
J el-On, and L Weinrauch, and R Livshin, and Z Even-Paz, and G P Jacobs
[Successful topical treatment of chronic cutaneous leishmaniasis with paromomycin sulfate (15%) and methylbenzethonium chloride (12%)].
November 1994, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
J el-On, and L Weinrauch, and R Livshin, and Z Even-Paz, and G P Jacobs
Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment of American cutaneous leishmaniasis: controlled study.
August 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
J el-On, and L Weinrauch, and R Livshin, and Z Even-Paz, and G P Jacobs
Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study.
January 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
J el-On, and L Weinrauch, and R Livshin, and Z Even-Paz, and G P Jacobs
Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate.
January 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
J el-On, and L Weinrauch, and R Livshin, and Z Even-Paz, and G P Jacobs
Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
November 1999, Journal of the European Academy of Dermatology and Venereology : JEADV,
J el-On, and L Weinrauch, and R Livshin, and Z Even-Paz, and G P Jacobs
[Topical treatment of persistent cutaneous leishmaniasis with paromomycin].
August 2007, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
J el-On, and L Weinrauch, and R Livshin, and Z Even-Paz, and G P Jacobs
Leishmania major: resistance of promastigotes to paromomycin, and susceptibility of amastigotes to paromomycin-methylbenzethonium chloride ointment.
June 1991, Annals of tropical medicine and parasitology,
J el-On, and L Weinrauch, and R Livshin, and Z Even-Paz, and G P Jacobs
Evaluation of paromomycin sulphate topical ointment as effective therapeutic agent in cutaneous leishmaniasis.
March 1996, JPMA. The Journal of the Pakistan Medical Association,
J el-On, and L Weinrauch, and R Livshin, and Z Even-Paz, and G P Jacobs
Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador.
January 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene,
Copied contents to your clipboard!